Page last updated: 2024-11-02

moxonidine and Goldblatt Syndrome

moxonidine has been researched along with Goldblatt Syndrome in 2 studies

moxonidine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Moxonidine is a second-generation, centrally acting antihypertensive drug with a distinctive mode of action."2.39Pharmacology of moxonidine, an I1-imidazoline receptor agonist. ( Ernsberger, P; Haxhiu, MA; Kaan, EC; Papp, JG; Ziegler, D, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, P1
Penner, SB1
Smyth, DD1
Ziegler, D1
Haxhiu, MA1
Kaan, EC1
Papp, JG1
Ernsberger, P1

Reviews

1 review available for moxonidine and Goldblatt Syndrome

ArticleYear
Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Journal of cardiovascular pharmacology, 1996, Volume: 27 Suppl 3

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cats; Dogs; Heart Rate; Hypertension

1996

Other Studies

1 other study available for moxonidine and Goldblatt Syndrome

ArticleYear
Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.
    British journal of pharmacology, 1994, Volume: 112, Issue:1

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Hemodynamics; Hypertension, Renovascular; Imidazol

1994